
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E

Net Margin
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
TR |
![]() |
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
|
1.3B TRY |
127%
|
|
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD |
-21 040%
|
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
327.3B USD |
7%
|
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
155.6B USD |
17%
|
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
135.1B USD |
21%
|
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.3B USD |
-9%
|
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
-392%
|
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
116.3B AUD |
18%
|
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
55.2B USD |
32%
|
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
-33%
|
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.4B USD |
-11%
|
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
Glance View
RTA Laboratuvarlari Biyolojik Ürünler Ilaç ve Makine Sanayi Ticaret AS engages in the production, research, and development in vitro diagnostics. Its diagnostic products include: Clinical Microbiology, such as chromogenic media, culture media in petri dishes, tubes and bottles, rodac petri surcheck, and tuberculosis diagnosis products; ELISA Kits, such as HBsAg ELISA Kit; Molecular Diagnostics, such as nucleic acid isolation kits, real-time PCR instruments, real-time PCR kits and RTA VOLTRAN voral detection system, as well as other tests. Its Research includes: dehydrated culture media, such as dehydrated chromogenic culture media; nucleic acid isolation kits and real-time PCR.

See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS's most recent financial statements, the company has Net Margin of 126.8%.